Socazolimab Biosimilar - Research Grade

Human

PD-L1

5mg/ml

IgG1 - lambda2

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

Q9NZQ7

Blue ice

Programmed death-ligand 1 (PD-L1) engages PD-1 to suppress T-cell responses and is a pivotal target in checkpoint-blockade research. This is a research-grade, unconjugated analog of socazolimab, a recombinant anti-PD-L1 monoclonal antibody supplied for research use only. Produced to in vivo standards with low endotoxin, it is available in scalable milligram to gram quantities for high-throughput and bulk laboratories. The reagent serves as a control and active component in PD-1/PD-L1 blockade functional assays, in vitro co-culture screens, and in vivo tumor-immunology models. Reproducible, high-purity preparation supports reliable results across repeated and large-scale experiments.

CD274ï؟½

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks